China National Accord Medicines Corporation Ltd. (SHE:000028)

China · Delayed Price · Currency is CNY

26.46

+0.01 (0.04%)

Apr 16, 2026, 10:10 AM CST

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Retail	20.98B	22.36B	-	24.11B	22.48B
Retail Growth	-6.16%	-	-	7.25%	15.64%
Distribution	53.32B	52.98B	-	50.20B	46.83B
Distribution Growth	0.64%	-	-	7.19%	14.03%
Headquarters	-	7.41M	-	5.38M	7.95M
Headquarters Growth	-	-	-	-32.35%	-16.21%
Offset of Business Segment	-	-969.77M	-	-867.28M	-960.33M
Total	74.30B	74.38B	-	73.44B	68.36B
Total Growth	-0.10%	-	-	7.44%	14.60%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
China	73.42B	74.38B	75.48B	73.44B	68.36B
China Growth	-1.29%	-1.46%	2.77%	7.44%	14.60%
Total	73.42B	74.38B	75.48B	73.44B	68.36B
Total Growth	-1.29%	-1.46%	2.77%	7.44%	14.60%

Source: S&P Global Market Intelligence.